AbCellera Biologics Inc. (ABCL) Financial Statements

Comprehensive financial analysis for ABCL including key ratios, revenue trends, profitability metrics, and analyst recommendations. Get detailed ABCL financial performance analysis and investment insights.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio (TTM):N/A

Forward P/E:-7.50

EPS (TTM):$-0.56

Enterprise Value:$871.00M

Profitability Ratios

Profit Margin:N/A

Return on Equity:-15.64%

Return on Assets:-10.96%

Operating Margin:-290.24%

Financial Health

Current Ratio:11.07

Quick Ratio:9.50

Debt to Equity:14.11

Beta (5Y):0.65

Revenue and Profit Trends

Growth Metrics

Revenue Growth

133.30%

Revenue Per Share

$0.11

Performance Metrics

0

Return on Equity

-15.64%

Return on Assets

-10.96%

Analyst Insights

Price Targets

Average Target

$9.29

High Target

$17.00

Low Target

$5.00

Analyst Recommendations

Recommendation

Strong Buy

Analyst Coverage

7 Analysts

Upside Potential

+122.7%